Public case informationLast updated

Hims & Hers Health Securities Class Action

Hims & Hers Health · Hims & Hers Health securities and telehealth services · Ongoing Litigation

About this case

A federal securities class action alleges that Hims & Hers Health and its executives made materially false or misleading statements or omitted information concerning the sharing of consumers' health information with third-party advertising platforms, prescription billing practices, and related regulatory and financial risks. The lawsuit has been filed and is ongoing, with a November 2, 2026 deadline for investors to seek appointment as lead plaintiff.

Case overview

Defendant company
Hims & Hers Health
Product or service
Hims & Hers Health securities and telehealth services
Court case number
3:26-cv-09313
Case status
Ongoing Litigation
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

settlement claim
Lead plaintiff application

Participation information

Settlement Claim

Investors who purchased or otherwise acquired Hims & Hers Health, Inc. securities between August 4, 2025 and July 29, 2026, inclusive, and suffered losses may seek appointment as lead plaintiff. Investors may also remain absent class members without seeking lead plaintiff status.

To seek lead-plaintiff status, an investor must file a motion with the United States District Court for the Northern District of California through counsel by November 2, 2026. Investors who do not seek lead-plaintiff status may remain absent class members.

Type
Settlement Claim
Status
Open
Reported proof requirement
Unclear

Lead plaintiff application

Investors who purchased or otherwise acquired Hims securities on the NASDAQ exchange between August 4, 2025 and July 29, 2026, and who suffered a loss, may seek appointment as lead plaintiff subject to court requirements.

File a motion with the court through counsel of choice no later than November 2, 2026. Investors may also choose to remain absent class members without seeking lead plaintiff appointment.

Type
Lead Plaintiff
Status
Open
Reported proof requirement
Unclear

Faruqi & Faruqi investor consultation

Investors who purchased or acquired Hims securities during the stated class period may contact Faruqi & Faruqi to discuss their legal rights and the lead plaintiff process.

Contact Faruqi & Faruqi, LLP using the telephone numbers provided in the notice or through the firm's HIMS information page.

Type
Law Firm Signup
Reported proof requirement
Unclear

Bernstein Liebhard Investor Inquiry

Investors are encouraged to contact Bernstein Liebhard LLP regarding the securities class action.

Submit the referenced form or contact Bernstein Liebhard LLP using the contact information provided in the article.

Type
Law Firm Signup

Sources